Get started

Genetics

CRSP on a major weekly level. What's coming next? Today we will take a look at CRISPR Therapeutics. Which are the main technical elements we can see here? a) The price is against a major Support/Resistance level, working since 2018. The price reaction on these zones tends to provide solid insight into future movements. b) Let's assume the price bounces on the current zone; what can we expect? - A movement towards the descending trendline around 100.00. IF that happens, that would be a take-profit level for me. Why? Because we tend to observe corrections once the price reaches a major level. You don't want to be insight a sideways movement for 100 days c) Let's assume that the price breaks the current level and keeps falling. What can we expect? - A movement towards the ascending trendline around 50.00. That would be the next level where I would start thinking again about bullish reversals. d) I'm a position trader. What is the most relevant level right now to develop setups? -If that's your case, I want to see first a breakout of the descending trendline; IF that happens, I want to see a correction of around 50 days. IF that is the case, I will be interested in trading that breakout for the long term. However, at the moment, we are far away from that situation, and I would stay away from this chart for long-term setups. Thanks for reading! Feel free to share your view of this in the comments.
NASDAQ:CRSP
by ThinkingAntsOk
1
HOW TO BE THE 1% 🤔💫🤩 Our culture is obsessed with the rich, famous, and successful people, yet what is left behind is both the hard work and sacrifices of those who «made it» And millions of those who failed miserably en route to fame and became nothing. There are multiple theories on and philosophical systems, that reflect on success, but ill bring out the key points:🔑 ➡️ Genetics, upbringing, and connections determine 70% of the outcome. Oh yes, as much as we don’t like to think about it, it is genetics that determines our capacity for sports, singing, our intelligence, speed of reaction, etc. For example, musical talent is determined by the specific structures in the brain, and some people have those from birth, and some people do not. These structures might differ by a factor of 10.000 from person to person, even though the brain size would be the same. So you might spend 20 years in musical training and be good, but you will never be a Mozart without those structures in your brain. Training and upbringing, In turn, affect whether you will be able to use these Brain structures, as well as the society in which you were born, determines if your talents will be useful or not. One might be born a genius mathematician, but if he did not get good training, or if he was born in the dark ages, his talent would have been wasted. One's family and social circle affect which connections will the person have in adult life , and it is for better or worse but cronyism and nepotism as still widespread, And the connected ones, even without being super bright, usually outdo those that aren’t. ➡️ Pareto 20/80 Rule, or risky business VS the safe one. Almost everything in life follows the Pareto Rule, which says that 20% of your effort brings you 80% of the result. There is another interpretation too: 20% of people will have 80% of all success in the given industry. This rule applies best and in its extremes to the high-end risky businesses with ultra-high failure rates paired with the ultra-high payoff. These industries are Acting, Music, Sports, and Trading! As you can see, in acting, which is the extreme case, 1% of the actors make 80% of the Income generated by the industry. The same goes for music and sports where the select few make the big buck, and those that aspired but failed, barely make a living. Compare this to being an engineer or a doctor. The failure rate is much lower, which lowers the risk of entering the profession, but the highest potential income is lower too! This applies to Trading too, as once you’ve learned how to be consistently profitable, the sky is the limit. There is no difference in the cost of labor or time spent on making a trade with the risk of 100$ and making a trade with the risk of 100.000$ Of course, at some point, your trades will get so big, that YOU will start moving the market trying to enter the trade, but that’s a story for another day. ➡️ Your power of will, determination, patience, and readiness for sacrifice. Trading is a unique industry, where ANYONE can succeed , without needing a diploma, connections, or looks. In essence, trading at its core is about pattern recognition . You discover a pattern, learn to find it on the chart, and then find a way to use this knowledge to extract monetary gains by playing this pattern with the probability being on your side. That's it. That easy. Then why is it, that 99.9% of those who try trading, ultimately fail? In my years of trading, I’ve noticed a pattern: 💡 A - GET RICH FAST attitude B - Do not spend time educating themselves C - Do not treat Trading like a business D - Lack of Patience E - Can not follow rules ⚠️ People think that forex is a Magic Money Tree, just stretch forth your hand, and you will drown in gold … In reality, however, learning to trade will take YEARS , will cost you a fortune and no one will guarantee you success. HERE IS MY ADVICE TO THE NEW TRADERS: 🤓 🎯 HAVE THE RIGHT MINDSET 1)Prepare for failure, disappointment, and tears 2)Realize that you will train for YEARS 3)Learn to fight and not to give up 🎯 GET GOOD HABITS: 1) We ARE our habits , so recognize what is good for you, and make it a habit 2)Staying in good health is underestimated, while in reality, your physical condition has a direct effect on your mind. 3) Work on your mistakes. You will never learn If you do not access your previous work critically. 4) Make a plan for a week , then break it into daily tasks. Do it for a month and that will become a habit. 🎯 MANAGE YOUR FINANCES WELL 1) Learning to trade is expensive and time-consuming, so make sure you have an income. 2) Learn basic financial literacy and spend less than you make. Easy right? But if you lose an account that cushion will help. 3) Do NOT quit your job the moment you became profitable. This sounds obvious, but the market will test you multiple times, and unless you’ve got enough savings to last for 1 YEAR without working, ditching a stable source of income will not only make you vulnerable but will also affect you mentally which will negatively affect your trading. 📈 FOLLOW these steps and you will increase your chances of success in trading by a factor of 10! PLEASE LIKE AND COMMENT TO GIVE ME A BOOST!
Education
by SignalProvider
14
Benitec Biopharma Inc. BNTC can explode anytime nowBenitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. (Source: Yahoo Finance) On April 15, 2020, the Company completed the re-domiciliation of the Company from Australia to the United States. As a result, the Company is now incorporated in the United States and its common stock is listed on Nasdaq. (Source: prnewswire.com) Market Cap 17.093M Please leave me a message if you want to test the buy and sell indicators that i am using.
NASDAQ:BNTCLong
by BuySellMarketMaker
2
$GSS - Genetics Signature is it time to buy now?On the weekly note, We have a weak bullish TK cross, prices have closed above the cloud which is a good sign that the current support at $0.38 holds. Currently it is a long term hold if you are looking into buying $GSS. Short term outlook: RSI is hovering close to oversold conditions, Chaikin Money Flow is dropping and that means the buying power is weakening. This is in line with the decreasing volume. For entries, see below for daily chart.
GLong
by paper_value
1
Arrowhead Pharmaceuticals Massive Institutional AccumulationStock tanked last year because hep b trials killed a chimp, so they shelved project to focus on Amgen and RNAi program therapies. Buy half now, buy the other half on a pullback. Fucking beautiful chart. BEAUTIFUL Only short to medium term risk is dilution, which is a very real possibility . The buying is just SO strong though, wow. BEAUTIFUL, like, it's ....just,.....its a beautiful chart. So firm and consistent, and green, with heavy volume. For it to have responded so strongly after a major investor left is very indicative of positive outcomes in the future. Late 2016 -Amgen to Receive Worldwide Exclusive License to Arrowhead's RNAi ARC-LPA Program -Amgen Receives Exclusive License Option to RNAi Therapy for Undisclosed Cardiovascular Target -Arrowhead to Receive $56.5 Million in Upfront Payments and Initial Equity Investment and up to an Additional $617 Million in ------Potential Milestone and Equity Payments up to $617 million in option payments, and development, regulatory and sales milestone payments "Arrowhead's expertise in RNAi makes them a valuable partner as we translate genetic discoveries into potential therapies that can improve health outcomes for patients," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen. "This collaboration builds upon our commitment to cardiovascular disease with targets that we believe are uniquely suited for RNAi-based therapy." "We have made great advances to our proprietary subcutaneous RNAi delivery vehicle and in RNAi trigger modification and stabilization that enable rapid development of new RNAi therapeutics across multiple disease areas," said Christopher Anzalone, Ph.D., president and chief executive officer at Arrowhead. "Our capabilities and platform technologies are becoming increasingly validated, so we feel that now is a great time to expand the reach of our technologies and partner with other companies to maximize the value of our assets. We are thrilled to be working with Amgen, one of the world's leading biotechnology companies, on this collaboration. Amgen's extensive development, regulatory, and commercial expertise makes them an ideal partner, and we look forward to a long and productive relationship."
NASDAQ:ARWRLong
by alipipefitter